Skip to main content

Zymeworks Inc 8-K/A, filed Nov 9, 2026

Zymeworks Inc. (ZYME)

8-K/A 2026-11-09 For: 2026-09-23
View Original
Added on November 10, 2026

About this 8-K/A

Zymeworks Inc filed this 8-K/A on November 9, 2026, reporting on events of September 23, 2026.

Zymeworks reports unaudited pro forma combined results, in thousands, of $321,163 revenue and $11,766 net income following its September 23, 2026 acquisition of Theravance. AI summary

Items reported

  • Item 9.01: Financial statements and exhibits